• Skip to main content
Indalo Therapeutics
  • About Us
    • Overview
    • Management
    • Board of Directors
    • Investors
    • Advisors
    • Academic Founders
  • Pipeline
    • Our Programs
    • Fibrotic Disease
  • Our Science
    • Targeting Integrins for Fibrosis
    • Publications
  • News
    • Articles
    • Press Releases
  • Contact Us
Investors
  • About Us
  • Overview
  • Management
  • Board of Directors
  • Investors
  • Advisors
  • Academic Founders

Investors include Atlas Venture, a leading biotech venture capital firm
Atlas Venture is a leading biotech venture capital firm. With the goal of doing well by doing good, it has been building breakthrough biotech startups for over 25 years. The firm works side-by-side with exceptional scientists and entrepreneurs to translate high impact science into medicines for patients. Atlas’s seed-led venture creation strategy rigorously selects and focuses investment on the most compelling opportunities to build scalable businesses and realize value.

 

Investors include F-Prime Capital Partners, a global venture capital firm.

F-Prime Capital Partners is a global venture capital firm investing in life sciences, healthcare, and technology. Since 1969, F-Prime has worked closely with entrepreneurs and academics to create innovative solutions to some of the world’s most significant challenges in healthcare and technology.

Indalo Therapeutics

Privacy Policy • Terms of Use • Sitemap
© 2019 Indalo Therapeutics, Inc.
Website Design & Development, Graphic Beans